logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

Pacific Shipping (02343) will distribute a final dividend of HK$0.06 per share on May 12th.

date
17:30 03/03/2026
avatar
GMT Eight
Pacific Shipping (02343) announced that the company will distribute a final dividend of HKD 0.06 per share for the year ending December 31, 2025 on May 12, 2026.
The Pacific Shipping (02343) announced that the company will distribute a final dividend of HK$0.06 per share for the year ending December 31, 2025 on May 12, 2026.
Related Articles
HK Stock
RIMAG GROUP (02522): Liu Senlin resigns as non-executive director.
HK Stock
Xd Inc (02400) spent HK$7.8857 million to repurchase 108,000 shares on March 3.
China Stock
Kexing Biopharm (688136.SH): GB19 Injection for the treatment of skin lupus erythematosus indications received approval notice for drug clinical trials.
RIMAG GROUP (02522): Liu Senlin resigns as non-executive director.
HK Stock
Xd Inc (02400) spent HK$7.8857 million to repurchase 108,000 shares on March 3.
HK Stock
Kexing Biopharm (688136.SH): GB19 Injection for the treatment of skin lupus erythematosus indications received approval notice for drug clinical trials.
China Stock
RECOMMEND
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
icon
02/03/2026
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
icon
02/03/2026
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
icon
02/03/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.